Signal active
Investment Firm
Overview
H.I.G. BioVentures invests in a broad range of life science companies across multiple sectors and stages of development. Their seasoned investment team has extensive and diverse experience in big pharma, small biotech, medical devices, diagnostics, basic science, clinical research, and technology transfer. They invest in companies developing novel products for significant unmet medical needs.
Highlights
2011
Venture Capital
501-1000
26
12
7
Early Stage Venture, Late Stage Venture
Venture Capital
Location
United States, North America
Contact Information
Social
Profile Resume
H.I.G. BioHealth Partners, established in 2011 and headquartered in United States, North America., specializes in Early Stage Venture, Late Stage Venture investments across Health Care, Manufacturing, Medical Device, Finance, Asset Management, Wealth Management, Venture Capital, Banking, Non Profit, Pharmaceutical. The organization boasts a portfolio of 26 investments, with an average round size of $31.4M and 7 successful exits. Their recent investments include NeuWave Medical, State of Wisconsin Investment Board, Venture Investors, Wisconsin Alumni Research Foundation, Intact Vascular. The highest investment round they participated in was $56.3B. Among their most notable exits are NeuWave Medical and State of Wisconsin Investment Board. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
26
3
12
7
Investments
26
Annouced Date | Organization Name | Industry | Money Raised |
---|---|---|---|
Jul 16, 2019 | Exagen | Biotechnology | 22.6M |
Oct 23, 2019 | Zerigo Health | Biotechnology | 18.0M |
May 27, 2020 | Arvelle Therapeutics | Biotechnology | 42.7M |
Oct 22, 2021 | Click Therapeutics | Biotechnology | 52.0M |
Exits
7
Funding Timeline
26
0
1
Funding Rounds
26
H.I.G. BioHealth Partners has raised 26 rounds. Their latest funding was raised on Oct 22, 2021 from a Series B - Click Therapeutics round.
Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
---|---|---|---|---|
Jul 16, 2019 | Venture Round - Exagen | - | 22.6M | - |
Oct 23, 2019 | Series A - Zerigo Health | - | 18.0M | - |
May 27, 2020 | Series A - Arvelle Therapeutics | - | 42.7M | - |
Oct 22, 2021 | Series B - Click Therapeutics | - | 52.0M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
Annouced Date | Fund Name | Money Raised |
---|---|---|
May 10, 2013 | OTPPLESS | 1.0M |
May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.